the problem
The Silent Crisis in Wound Care and Infection Control
- Each year, millions of patients worldwide suffer from wounds that fail to heal or become infected.
- Antibiotic resistance is rising, leaving traditional treatments less effective and more dangerous.
- In hospitals, surgical site infections affect 2-5% of all surgeries, costing billions annually.
- Low and middle-income countries face limited access to clean wound treatment, compounding risks.
- Current solutions are slow, expensive, or ineffective at eradicating harmful bacteria at the wound site.
the market opportunity
A $20B+ Global Opportunity to Transform Infection Control
- The global advanced wound care market is projected to reach $27.8B by 2030, with rapid growth in light-based therapies.
- Hospitals, military, and home-health providers urgently need non-invasive, antimicrobial tools to reduce infections and healing time.
- Our plasma-based technology targets a multi-billion dollar vertical in both high-income countries and resource-limited settings.
- PlasmaPulse is uniquely positioned to reduce hospital readmissions, accelerate wound healing, and combat antibiotic-resistant bacteria.
- Future opportunities include burn treatment, diabetic ulcers, surgical recovery, and mobile wound care units.